Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”

• Francisco Ciruela,
• Francisco Ciruela,
• Kjell Fuxe,
• Peter Illes,
• Peter Illes,
• Henning Ulrich,
• Henning Ulrich,
• Francesco Caciagli

Affiliations

Francisco Ciruela

Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L’Hospitalet de Llobregat, Spain

Francisco Ciruela

Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, IL’Hospitalet de Llobregat, Spain

Kjell Fuxe

Department of Neuroscience, Karolinska Institutet, Biomedicum, Stockholm, Sweden

Peter Illes

Rudolf Boehm Institute for Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

Peter Illes

International Collaborative Centre on Big Science Plan for Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, China

Henning Ulrich

International Collaborative Centre on Big Science Plan for Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, China

Henning Ulrich

Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil

Francesco Caciagli

Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy